Skip to main content
PLOS One logoLink to PLOS One
. 2022 Jul 27;17(7):e0268218. doi: 10.1371/journal.pone.0268218

Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP study

Cristina M Lozano-Hernández 1,2,3,4,*, Juan Antonio López-Rodríguez 1,3,4,5,6, Milagros Rico-Blázquez 1,3,7, Amaia Calderón-Larrañaga 3,8,9,10, Francisca Leiva-Fernández 3,11,12, Alexandra Prados-Torres 3,10, Isabel del Cura-González 1,3,5; MULTIPAP GROUP
Editor: Thomas Penzel13
PMCID: PMC9328549  PMID: 35895702

Abstract

The beneficial effects of social support on morbidity, mortality, and quality of life are well known. Using the baseline data of the MULTIPAP study (n = 593), an observational, descriptive, cross-sectional study was carried out that analyzed the sex differences in the social support perceived by polymedicated adults aged 65 to 74 years with multimorbidity. The main outcome variable was social support measured through the Duke–UNC-11 Functional Social Support (DUFSS) questionnaire in its two dimensions (confident support and affective support). For both sexes, the perception of functional social support was correlated with being married or partnered and having a higher health-related quality of life utility index. In women, it was correlated with a higher level of education, living alone, and treatment adherence, and in men with higher monthly income, prescribed drugs and fewer diagnosed diseases.

Introduction

Sociodemographic, environmental, and psychosocial factors can increase the probability of developing health problems [1]. Psychosocial factors such as lack of social support and loneliness have been associated with a higher mortality rate of older adults. In this population group, larger social networks are associated with up to 50% higher probability of survival [2].

Although it is not known exactly how social support affects health status, it has both direct and indirect influences. On the one hand, it seems to influence stress and affective changes through the hormonal system and, on the other hand, in behavior, conditioning people’s lifestyles [3, 4]. Certain mental health conditions are related to a low perceived social support by the individual, such as anxiety disorders and depression [5, 6]. Likewise, having lower adherence to prescribed treatment and poor health habits has been directly related to having low social support [79].

The conceptualization and measurement of social support is a subject of controversy among experts. Not all authors agree on the identification of its dimensions. Norbeck et al. [10] state that the dimensions of social support are so highly correlated that they are difficult to distinguish. Broadly speaking, social support can encompass two dimensions. First, the structural dimension, also called the social network, evaluates the number of links an individual has to others and their interconnections, taking into account the size, frequency of contacts, composition, density, kinship, homogeneity, and strength [11]. Authors such as Hughes et al. and Umberson et al. [12, 13] have suggested that marriage positively influences the healthy behaviors of the individual and therefore their health status. Second, the functional dimension corresponds to the perception of available support flowing through the links of the social network. Dimatteo et al. and Li et al. [7, 14] showed that the network of family and close friends offers more useful social support for the individual than the support of circumstantial friends and acquaintances. One of the most widely used instruments to study perceived functional social support is the Duke-Unk-11, Functional Social Support questionnaire (DUFSS) developed by Broadhead et al. [15]. It originally consisted of 14 items that Broadhead reduced to 11 items in its first validation, and after factor analysis the two-dimensionality of the questionnaire was confirmed. It was identified that on the one hand it measures "confidential support" (the possibility of having people to communicate with) and on the other hand it measures "affective support" (demonstrations of love, affection and empathy).

There are important sex differences in social support and in how women and men perceive it due to sex roles. Traditionally, in men, stereotypes of independence, reflection, aggressiveness, stability, strength, and competitiveness have been emphasized, them being the figure in charge of the defense, production, and economic support of the family, while in women, the stereotypes have been dependency, emotionality, sweetness, instability, weakness, and prudence, them being the family figure linked to care, reproduction, and raising children [16, 17]. According to Cable et al. [18], men report receiving more support from their partners, who are their main source of social support, affirming that marriage has a beneficial effect on psychological well-being and reduces their risk of mortality. Kaplan et al. and Walen et al. [19, 20] have seen that women, on the contrary, more strongly value the support received from their social network of friends, family, and coworkers, resorting to sources outside their partner more frequently than men do [21, 22].

Studies by Berkman and Chen suggest that the relationship between social support and health status is stronger in women [23, 24]. Over their lifetime, women have more comorbidities, multimorbidity, and polymedication and tend to report a lower health-related quality of life (HRQoL) than men of the same age, despite having a lower mortality rate and higher life expectancy [2528]. Precisely due to their longevity, it has been seen that when women reach a certain age, they have less structural social support than men in the same situation, more often finding themselves living alone [2932].

The study of the impact of social support, and potential sex differences, in patients with chronic conditions has focused mainly on isolated diseases. Chronicity and longevity tend to generate a need for complex care due to two converging situations in older individuals: multimorbidity, defined as two or more concurrent chronic medical conditions (the threshold of three being more specific for identifying patients with complex health needs) [33], and polypharmacy, defined as the simultaneous consumption of five or more drugs by the same person [34, 35]. The mean number of chronic problems in the in young senior patients (65–74 years) is estimated to be 2.8 [33, 36, 37], being an understudied age group with an important potential for early intervention.

The main aim of this study is to analyze sex differences in perceived (i.e. functional) social support by polymedicated old adults 65 to 74 years with multimorbidity.

Materials and methods

An observational, descriptive, cross-sectional study was conducted with an analytical approach using the baseline data of the MULTIPAP study [38]. This intervention study was conducted in 38 health centers in the regions of Andalusia, Aragon, and Madrid (Spain). Patients aged 65–74 years with multimorbidity (≥3 diseases) and polymedication (≥5 different drugs during at least the last 3 months) who had visited their family doctor at least once in the past year and provided written informed consent to participate in the MULTIPAP study [38] were included. Patients residing in nursing homes, with severe mental illness, or with a life expectancy of less than 12 months were excluded. Those patients who met the inclusion criteria were selected by cluster randomised sampling during visits with the 117 participating professionals; five patients per family doctor were enrolled.

The data were collected by previously trained professionals through an interview at the practice. Sociodemographic variables were collected: sex, age, level of education (below primary education, completed primary education, high school, or higher), and professional occupation according to the skill level required by each job through the ISCO-08 [39] (low, medium, or high level). The social class of the household was measured through the CNO-11 [40] (grouped from lowest to highest as VI, V, and I-IV) and monthly household income (≤1050 €/month, 1051–2250 €/month, or ≥2251 €/month). The following clinical variables were collected: number of chronic conditions, number of drugs prescribed, diagnosis of depressive disorder and/or anxiety state or disorder, self-reported treatment adherence through the four-item Morisky–Green–Levine Medication Evaluation Questionnaire (MGL MAQ) (0.61 Cronbach’s alpha) [41], and HRQoL measured by the EQ-5D-5L [42]. The validated version of the EQ-5D-5L questionnaire for the Spanish population was used [43], which consists of two parts. The first part consists of five questions related to mobility, self-care, daily activities, pain/discomfort, and anxiety/depression. Each one is scored from 1 to 5 points, and from these five questions, a single weighted score is obtained, the Utility Index (EQ-5D-5L Utilities). The scoring for this scale ranges from full health, with a value of 1, to death, with a value of 0, although negative values are allowed. To calculate this index, the algorithm proposed for Spain was used [44]. The second part is a visual analog scale (EQ-5D-5L VAS) that ranges from 0 (worst state) to 100 (best possible health state).

Structural social support was measured through marital status and number of cohabitants in the home. To explore the functional social support, a patient-reported measure was used, namely, the Duke UNC-11 Functional Social Support (DUFSS) questionnaire, which offers a total functional support score and two additional scores referring to the dimensions of confident and affective support [45]. We used the 11-item version with Likert responses of 1 (“much less than I would like”) through 5 (“as much as I would like”) [46]. The DUFSS questionnaire has been validated in different populations, showing differences in the distribution of the items that make up each of its dimensions. For our study, we chose the validation performed in a noninstitutionalized Spanish population over 65 years of age by Ayala et al. with 0.95 Cronbach’s alpha [47]. Its factorial analysis groups items 4, 5, 6, 7, 8, 10, and 11 into the dimension of “confident” support, with a total score of 35, and items 1, 2, 3, and 9, into the dimension of “affective” support, with a total score of 20.

Analytic plan

The characteristics of study participants and of the social support components were described as frequencies and percentages for qualitative variables and as means ± standard deviations (SD) (normally distributed) or medians and interquartile ranges (IQR) (nonnormally distributed) for quantitative variables. To analyze the associations between the different dimensions of social support and sex, Pearson’s chi-squared test was used for qualitative variables and Student’s t-test for quantitative variables. Confidence intervals were estimated at 95%.

To study the factors associated with greater functional social support, an explanatory linear regression model was constructed for women and men separately. The dependent variable was functional social support measured through the total score of the DUFSS questionnaire. The independent variables were those that showed statistical significance in the bivariate analysis or were considered relevant in the conceptual framework of the study. Since patients were recruited grouped by clusters (i.e. their family physician), all the estimations were carried out with robust estimators. The analyses were performed with STATA v.14.

The project was approved by the Clinical Research Ethics Committee of Aragon (CEICA) on September 30, 2015. It was favorably evaluated by the Research Ethics Committee of the Province of Malaga on September 25, 2015 and the Central Research Commission of Primary Care of the Community of Madrid on March 16, 2016.

Results

Of the 593 patients included in the study, 55.8% were women. The mean age of the study population was 69.7 (2.7). Among patients who had not completed their primary studies, the majority were women (64.5% vs. 35.5%, p < 0.001). Women were also highly represented among those with lower-skill occupations (83.6% vs. 16.4%, p < 0.001) and with the lowest monthly household income (68% vs. 31.8%, p < 0.001).

In relation to health status, women had a higher frequency of depressive disorder (82% vs. 18%, p < 0.001) and anxiety disorder (77% vs. 23%, p < 0.001) than men. No statistically significant difference was found in the number of diagnosed diseases or the number of prescribed drugs. Regarding HRQoL measured by the VAS, women reported a health status 7 points lower than men (69.5 ± 20 vs. 62.5 ± 20.4, p < 0.001). Moreover, women more often presented some type of problem in any of the dimensions of HRQoL: mobility (61% vs. 39%, p = 0.01); daily activities (73% vs. 27%, p < 0.001); pain/discomfort (40.4% vs. 59.6%, p = 0.001); and anxiety/depression (29.5% vs. 70.5%, p < 0.001). Women had a lower score in utilities than men (0.73 ± 0.2 vs. 0.82 ± 0.2). Table 1 describes the characteristics of the sample according to sex.

Table 1. Characteristics of the sample according to sex.

Total n (%) Men n (%) Women n (%)
593(100) 262(44.2) 331 (55.8)
    Sociodemographic
    Age m (SD) 69.7(2.7) 69.8(2.6) 69.7(2.7)
    Educational level
    Did not complete primary studies 279(47.1) 99(37.8) 180(54.4)
    Completed primary studies 196(33.1) 82(31.3) 114(34.4)
    Bachelor or higher 118(19.9) 81(30.9) 37(11.2) ***
    Occupation skill level
    Level 1 232(39.1) 38(14.5) 194 (58.6) ***
    Level 2 249(42) 158 (60.3) 91 (27.5)
    Level 3 80(13.5) 41(15.7) 39(11.8)
    Level 4 32(5.4) 25(9.5) 7(2.1)
    Social class of the household
    VI 142(24) 58(22.1) 84(25.4)
    V 217(36.6) 84(32.1) 133(40.2)
    IV-I 234(39.5) 120(45.8) 114(34.4) *
    Monthly household income
< = 1.050 €/month 170(28.7) 54(20.6) 116(35.1)
1.051–2.250 €/month 342(57.7) 160(61.1) 182(54.9)
≥2.251 €/month 59(10) 39(14.9) 20(6.0) ***
    NS/NC 22(4) 9(3.4) 13(3.9)
Clinical
    Median number of diseases (IQR) 5(4–7) 5(4–7) 5(4–7)
    Depressive disorder 110(18.6) 20(18.2) 90(81.8) ***
    Anxiety state or disorder 88(914.8 20(22.7) 68(77.3) ***
    Median number of drugs (IQR) 7(6–9) 7(5–9) 7(6–9)
    MGL MAQ m (SD) 351(59.2) 155(44.2) 196(55.8)
    HRQoL
EQ5D5 L VAS m (SD) 65.5(20.5) 69.5(20) 62.4(20.5) ***
EQ5D5 L Utilities m (SD) 0.77(0.2) 0.82(0.2) 0.73(0.2) ***
Mobility
    No problems 293 (49.4) 145 (55.3) 148 (44.7) **
    Some type of problem 300 (50.6) 117 (44.7) 183 (55.3)
Personal care
    No problems 505 (85.2) 227 (86.6) 278 (84.0)
    Some type of problem 88 (14.8) 35 (13.4) 53 (16.0)
Daily activities
    No problems 411 (69.3) 213 (81.3) 198 (59.8)
    Some type of problem 182 (30.7) 49 (18.7) 133 (40.2) ***
Pain/discomfort
    No problems 145 (24.5) 81 (30.9) 64 (19.3)
    Some type of problem 448 (75.6) 181 (69.1) 267 (80.7) **
Anxiety/depression
    No problems 308 (51.9) 178 (67.9) 130 (39.3) ***
    Some type of problem 285 (48.1) 84(32.1) 201(60.7)

Note: m = median; SD = standard deviation; IQR = interquartile range.

* p < .05

** p < .01

*** p < .001

Of the 593 patients, 106 (17.9%) lived alone, of whom 79.3% were women. Men lived in households with three or more cohabitants more frequently than women (59.7% vs. 40.3%, p = 0.009). Sixteen percent of the patients were widowers, and 89.4% of them were women. The mean score of functional social support was 43.7 ± 8.8, with women scoring 2 points lower than men (p = 0.004). Table 2 describes the components of social support by sex. The difference in score between the dimensions of functional support for men and women was 1.3 points in the “confident” support dimension and 0.8 points in the “affective” dimension, both scores being lower in women. Table 3 describes the distribution of the DUFSS questionnaire scores by sex. Significant differences by sex appeared regarding the category "Much less/less than I would like" in the items: I get chances to talk to someone about problems at work or with my housework (7.3% vs. 14.2%, p = 0.008); I get chances to talk about money matters (7.6% vs. 13.9%, p = 0.03); I get help when I´m sick in bed (5.7% vs. 13.6%, p = 0.002); I get help around the house (29.8% vs. 37.8%, p = 0.04); I get praise for a good job (16.0% vs. 25.1%, p = 0.007).

Table 2. Components of social support by sex.

Total n (%) Male n (%) Female n (%)
593(100) 262(44.2) 331 (55.8)
Structural Social Support
Living alone 106(17.9) 22(8.4) 84(25.4) ***
Living with
2 people 368(75.6) 169(70.4) 199(80.6) **
≥ 3 people 119(24.4) 71(29.6) 48(19.4)
Marital status
Single 23(3.9) 11(4.2) 12(3.6)
Married 447(75.4) 228(87.0) 219(66.2)
Separated 29(4.9) 13(5.0) 16(4.8)
Widower 94(15.9) 10(3.8) 84(25.4) ***
Functional Social Support (DUFSS)
Total score, m (SD) 43.7(8.8) 44.9(8.3) 42.8(9) **
1st tertile (low) 190(32) 70(26.7) 120(36.3)
2nd tertile (medium) 191(32.2) 88(33.6) 103(31.1) *
3rd tertile (high) 212(35.8) 104(39.7) 108(32.6)
“Confident” score, m (SD) 29.5(5.9) 30.2(5.7) 28.9(6.1) **
“Affective” score, m (SD) 14.2(3.7) 14.7(3.5) 13.9(3.7) *

Note: m = mean; SD = standard deviation; IQR = interquartile range.

* p < .05

** p < .01

*** p < .001

Table 3. DUFSS questionnaire score by sex.

Total n (%) 593(100) Male n (%) 262(44.2) Woman n (%) 331 (55.8) p
    Confident Dimension
    Item 4. I get people who care what happens to me
     Much less/less than I’d like 49(8.3) 21(8.0) 28(8.5)
    Neither a lot nor little/almost/as much as I would like 544(91.7) 241(92) 303(91.5)
    Item 5. I get love and affection
     Much less/less than I would like 59(10) 21(8.0) 38(11.5)
    Neither a lot nor little/almost/as much as I would like 534(90.1) 241(92) 293(88.5)
    Item 6. I get chances to talk to someone about problems at work or with my housework
    Much less/less than I would like 66(11.13) 19(7.3) 47(14.2) **
    Neither a lot nor little/almost/as much as I would like 527(88.9) 243(92.8) 284(85.8)
    Item 7. I get chances to talk to someone I trust about my personal and family problems
    Much less/less than I would like 70(11.8) 25(9.5) 45(13.9)
    Neither a lot nor little/almost/as much as I would like 523(88.2) 237(90.5) 286(86.4)
    Item 8. I get chances to talk about money matters
     Much less/less than I would like 66(11.1) 20(7.6) 46(13.9) *
    Neither a lot nor little/almost/as much as I would like 527(88.9) 242(92.4) 285(86.1)
    Item 10. I get useful advice about important things in life
    Much less/less than I would like 61(10.3) 25(9.5) 36(10.9)
    Neither a lot nor little/almost/as much as I would like 532(89.7) 237(90.5) 295(89.1)
    Item 11. I get help when I´m sick in bed
    Much less/less than I would like 60(10.1) 15(5.7) 45(13.6) **
    Neither a lot nor little/almost/as much as I would like 533(89.9) 247(94.3) 286(86.4)
    Affective Dimension
Item 1. I get visits with friends and relatives
    Much less/less than I would like 140(23.6) 55(21) 85(25.7)
    Neither a lot nor little/almost/as much as I would like 453(79) 207(45.7) 246(74.3)
    Item 2. I get help around the house
    Much less/less than I would like 203(34.2) 78(29.8) 125(37.8) **
    Neither a lot nor little/almost/as much as I would like 390(65.8) 184(70.2) 206(62.2)
Item 3. I get praise for a good job
    Much less/less than I would like 125(21.1) 42(16.0) 83(25.1) **
     Neither a lot nor little/almost/as much as I would like 468(78.9) 220(48) 248(74.9)
Item 9. I get invitations to go out and do things with other people
    Much less/less than I would like 116(19.6) 48(18.3) 68(20.5)
    Neither a lot nor little/almost/as much as I would like 477(80.4) 214(81.7) 263(79.5)

Note

* p < .05

** p < .01

*** p < .001

For both sexes, the variable most strongly associated with functional social support was the one referring to utilities in the HRQoL. Table 4 shows the factors associated with functional social support in women and men. For every 1-point increase in the utility score, functional social support increased 11.5 points (95% CI 7.09; 15.85) in women and 9.4 points (95% CI 3.18; 15.59) in men. Being married or partnered was also associated to perceived social support in both women and men, but more strongly in the latter (4.2 points, 95% CI 1.26; 7.07 vs. 3.3 points, 95% CI 0.29; 6.24). The rest of the variables associated to functional social support were different for each sex. In women, the functional social support score increased by 5 points (95% CI 1.91;7.94) in those who had completed high school or higher education; 2 points (95% CI 0.08;3.78) in those adhering to the prescribed treatment; and 5.6 points (95% CI 2.42;8.83) in those who lived alone. In men, the functional social support score increased by 3 points (95% CI 0.74; 5.70) in those with a household income between 1.051–2.250 €/month and 0.5 points (95% CI 0.03; 0.90) for each prescribed drug. Fig 1 shows the magnitude of the association for each of the variables that the final model yielded for both sexes.

Table 4. Factors associated with functional social support in women and men.

Women
Coef. (95% CI) p value
  Educational level
    Completed primary studies 2.33(0.34;4.32) 0.022
    Bachelor or higher 4.92(1.91;7.94) 0.001
  Adherence, compliance (Morisky-Green) 1.93(0.08;3.78) 0.041
  Utility index 11.47(7.09;15.85) 0.000
  Live alone 5.63(2.42;8.83) 0.001
  Married or partnered 3.27(0.29;6.24) 0.031
  R2 0.1604
  Men
Coef. (95% CI) p value
  Monthly household income
    1.051–2.250€/month 3.22(0.74;5.70) 0.011
    ≥2.251€/month 2.30(-1.04;5.65) 0.176
  Number of diseases -0.42(-0.87;0.30) 0.067
  Number of drugs 0.47(0.03;0.90) 0.036
  Utility index 9.38(3.18;15.59) 0.003
  Married or partnered 4.16(1.26;7.07) 0.005
  R2 0.1108

Fig 1. Differences by sex found in the final model.

Fig 1

Discussion and conclusions

There are important sex differences in the social support perceived by polymedicated young-old patients with multimorbidity. These differences must be interpreted bearing in mind the age range studied, i.e. those born in Spain in the 1940s and 1950s, when social differences between men and women were still quite marked [48].

The functional social support score reported by women was lower than that reported by men, coinciding with previous studies conducted in similarly aged populations from Spain and Brazil [21, 43]. Being the main source of care and support for others can hinder women’s role as a recipient of support from others, which could explain why women, unlike men, have stated that they would like to be better listened to about their problems, hear more praise when they do something well, and get more help when they are sick [29].

The lower social support score perceived by women could also be explained by the fact that social networks are importantly influenced by sex inequalities within social structures. Women with worse educational and occupational level tend to perceive lower social support [25, 45]. In contrast, in men, the perception of social support seems to be related to their income level. Accordingly, a German study found that living in the most socially disadvantaged municipalities was associated with low social support in men, but not in women, which suggests that for men the perception of social support is related to their success in their role as household economic providers, represented in our study by income [49].

For both sexes, being married or partnered increased the perception of social support, observing a stronger association in the case of men, as described by other authors who have found that men’s main sources of support are their partners [50]. The increasing feminization of old age has meant that widowhood is a mostly female experience [51]. More and more widowed men and women are living alone, but women do so more often than men, who usually live with someone [52]. Women, when widowed, may feel very supported by social networks that, until then, had not been their main source of support, such as children, other family members, and friends, and may thus perceive greater social support in this new situation [18].

Perceived social support was directly correlated with the utility index of HRQoL in both sexes. In women this relationship was most intense, and they reported worse scores in all dimensions of HRQoL, along the lines of previous research [53]. Different authors have linked family demands with a worse quality-of-life score, especially in women with lower socioeconomic status [54].

Regarding polypharmacy, in men, better perceived social support was associated with a higher number of prescribed drugs and, in women with better adherence to treatment. This association could be explained by the effectiveness of the treatment, which may improve their health status and symptoms, allowing them to carry out social activities. In the case of women, such an association might be explained by the acceptance and social recognition that they can experience when performing self-care in a socially accepted way [29].

Perceived support is a multidimensional construct subject to different interpretations by experts in the field, for which a consensus is not reached with respect to the dimensions that compose it or how to measure it. Different validations have been carried out on the questionnaire used in this study (DUFSS) in very specific populations, such as caregivers [55], mental health patients [56], or socioeconomically disadvantaged people, and they were mostly women [11, 41]. In our study, we chose to use the most recent validation performed by Ayala et al. [47], who obtained a Cronbach’s alpha of 0.94 in noninstitutionalized people aged 60 or over; their population was similar to ours and allows better comparisons with our results.

Limitations and strengths

The study of social support presents difficulties in relation to conceptualisation and measurement. In this study, structural social support has been studied through a proxy of the social network such as marital status and the number of cohabitants in the household. This is undoubtedly a limitation, since the structural perspective studies social networks, including all the individual’s contacts and providing information on their dimensions, and not only the variables available in this research. However, despite this limitation, this proxy allows us to cover part of the structural social support, following the recommendations of the authors who state that it is more appropriate to study both types of support, functional and structural.

The data used in this study are the baseline data from a randomised clinical trial, MULTIPAP STUDY [38]. It is a pragmatic cluster randomised controlled clinical trial with 12 months follow-up. The unit of randomisation was the family doctor and the unit of analysis was the patient. Although this was a cross-sectional study, its external validity was increased through systematic random sampling drawn from a representative sampling frame. The sample was drawn from a heterogeneous sample that is representative of the general multimorbid and polymedicated population… This was achieved by selecting patients from the health centers, by their family physicians, under clinical practice conditions, giving a pragmatic outlook to the study. The restriction of the sample to the age group of young older adults aged 65 to 74 years makes the sample size difficult, but, at the same time, offers greater knowledge about this group, which is rarely studied on its own but increasingly prominent in our society.

Important sex differences exist in the social support perceived by older multimorbid adults, which should be considered in future public health and health promotion interventions.

Acknowledgments

To our colleagues from the Research Unit Primary Health Care Management Madrid for their support. To all the professionals from the participant Primary Healthcare Centers. To all patients for their contribution to this research.

MULTIPAP GROUP:

Lead authors for the MULTIPAP Study group: Alexandra Prados Torres (Aragonese Institute of Health Sciences (IACS), IIS Aragón, Miguel Servet University Hospital, Spain) sprados.iacs@aragon.es, Juan Daniel Prados Torres (Multiprofessional Teaching Unit for Family and Community Care Primary Care District Málaga-Guadarhorce. Málaga) juand.prados.sspa@juntadeandalucia.es, Isabel del Cura (Research unit. Primary Health Care Management Madrid. Spain) isabel.cura@salud.madrid.org.

Coordinating Committee

José María Abad-Díez (Department of Health, Social Welfare and Family, Government of Aragon), Marta Alcaraz Borrajo (Subdirectorate General of Pharmacy and Health Products), Paula Ara Bardají (Aragonese Institute of Health Sciences (IACS), IIS Aragón, Miguel Servet University Hospital, Spain), Gloria Ariza Cardiel (Research unit. Primary Health Care Management Madrid. Spain), Mercedes Aza-Pascual-Salcedo(Primary Care Department, Aragonese Health Service.), Amaya Azcoaga Lorenzo (Pintores Primary Health Care Centre, Madrid, Spain), Ana Cristina Bandrés-Liso (Primary Care Department, Aragonese Health Service.), Mercedes Clerencia-Sierra (Unit of Social and Health Assessment, Miguel Servet University Hospital, Aragonese Health Service), Nuria García-Agua (Department of Pharmacology, Faculty of Medicine, Malaga University), Luis Gimeno Feliu(San Pablo Primary Health Care Centre, Aragon Health Service, Zaragoza, Spain), Antonio Gimeno-Miguel(Aragonese Institute of Health Sciences (IACS), IIS Aragón, Miguel Servet University Hospital, Spain), Ana I González González(Technical Support Unit, Primary Care Management, Madrid Health Service), Virginia Hernández Santiago(Ninewells Hospital & Medical School, Dundee, UK), Francisca Leiva Fernández (Multiprofessional Teaching Unit for Family and Community Care Primary Care District Málaga-Guadarhorce. Málaga), Ana Mª López-León (Alhaurín el Grande Health Center, Malaga / Guadalhorce Sanitary District), Juan A López Rodríguez (Research unit. Primary Health Care Management Madrid. Spain), Cristina M Lozano Hernández (Research unit. Primary Health Care Management Madrid. Spain), María Isabel Márquez-Chamizo(Carranque Health Center, Malaga / Guadalhorce Sanitary District.), Alessandra Marengoni(Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy), Javier Marta-Moreno(Department of Neurology, University Hospital Miguel Servet, Aragonese Health Service.), Jesús Martín Fernández(Villamanta Primary Health Care Centre, Madrid, Spain), Angel Mataix SanJuan(Subdirección General de Farmacia y Productos Sanitarios), Carmina Mateos-Sancho(Ciudad Jardín Health Center, Malaga / Guadalhorce Sanitary District), Christiane Muth(Institute of General Practice, Johann Wolfgang Goethe University, Frankfurt, Germany), Victoria Pico Soler(Torrero-LaPaz Health Center, Zaragoza, Spain), Beatriz Poblador Plou (Aragonese Institute of Health Sciences (IACS), IIS Aragón, Miguel Servet University Hospital, Spain), Elena Polentinos Castro(Research unit. Primary Health Care Management Madrid. Spain), Antonio Poncel-Falcó (Primary Care Department, Aragonese Health Service.), Ricardo Rodríguez Barrientos (Research unit. Primary Health Care Management Madrid. Spain), José María Ruiz-San-Basilio (Coín Health Center, Malaga / Guadalhorce Sanitary District), Mercedes Rumayor Zarzuelo (6 Centro de Salud Pública de Coslada, Área II Subdirección de Promoción de la Salud y Prevención), Luis Sánchez Perruca (Dirección Sistemas de Información, Gerencia Asistencial de Atención Primaria, Servicio Madrileño de Salud), Teresa Sanz Cuesta (Research unit. Primary Health Care Management Madrid. Spain), Mª Eugenia Tello Bernabé (El naranjo Primary Health Care Centre, Madrid, Spain.), José María Valderas Martínez (University of Exeter Medical School, Exeter, UK. 22Department), Rubén Vázquez-Alarcón (Vera Health Center, AGS Norte de Almería).

Clinical Investigators in Primary Healthcare Centres (PHC) MULTIPAP GROUP:

(Andalucía): PCHC Alhaurín el Grande Javier Martín Izquierdo, Macarena Toro Sainz. PCHC Carranque Andalucía): Mª José Fernández Jiménez, Esperanza Mora García, José Manuel Navarro Jiménez.PCHC Ciudad Jardín Andalucía):: Deborah Gil Gómez, Leovigildo Ginel Mendoza, Luz Pilar de la Mota Ybancos, Jaime Sasporte Genafo.PCHC Coín Andalucía):: Mª José Alcaide Rodríguez, Elena Barceló Garach, Beatriz Caffarena de Arteaga, Mª Dolores Gallego Parrilla, Catalina Sánchez Morales.PCHC Delicia Andalucía): s: Mª del Mar Loubet Chasco, Irene Martínez Ríos, Elena Mateo Delgado.PCHC La Roca Andalucía):: Esther Martín Aurioles.PCHC Limonar Andalucía):: Sylvia Hazañas Ruiz.PCHC Palmilla Andalucía):: Nieves Muñoz Escalante.PCHC Puerta Blanca Andalucía):: Enrique Leonés Salido, Mª Antonia Máximo Torres, Mª Luisa Moya Rodríguez, Encarnación Peláez Gálvez, José Manuel Ramírez Torres, Cristóbal Trillo Fernández. PCHC Tiro Pichón Andalucía): Mª Dolores García Martínez Cañavate, Mª del Mar Gil Mellado, Mª Victoria Muñoz Pradilla. PCHC Vélez Sur Andalucía): Mª José Clavijo Peña, José Leiva Fernández, Virginia Castillo Romero.PCHC Victoria Andalucía): Rafael Ángel Maqueda, Gloria Aycart Valdés, Miguel Domínguez Santaella, Ana Mª Fernández Vargas, Irene García, Antonia González Rodríguez, Mª Carmen Molina Mendaño, Juana Morales Naranjo, Catalina Moreno Torres, Francisco Serrano Guerra. Aragón: PCHC Alcorisa (Alcorisa): Carmen Sánchez Celaya del Pozo.PCHC Delicias Norte (Zaragoza): José Ignacio Torrente Garrido, Concepción García Aranda, Marina Pinilla Lafuente, Mª Teresa Delgado Marroquín.PCHC Picarral (Zaragoza): Mª José Gracia Molina, Javier Cuartero Bernal, Mª Victoria Asín Martín, Susana García Domínguez. PCHC Fuentes de Ebro (Zaragoza): Carlos Bolea Gorbea.PCHC Valdefierro (Zaragoza): Antonio Luis Oto Negre. PCHC Actur Norte (Zaragoza): Eugenio Galve Royo, Mª Begoña Abadía Taira.PCHC Alcañiz (Alcañiz): José Fernando Tomás Gutiérrez. PCHC Sagasta—Ruiseñores (Zaragoza): José Porta Quintana, Valentina Martín Miguel, Esther Mateo de las Heras, Carmen Esteban Algora. PCHC Ejea (Ejea de los Caballeros): Mª Teresa Martín Nasarre de Letosa, Elena Gascón del Prim, Noelia Sorinas Delgado, Mª Rosario Sanjuan Cortés. PCHC Canal Imperial—Venecia (Zaragoza): Teodoro Corrales Sánchez. PCHC Canal Imperial—San José Sur (Zaragoza): Eustaquio Dendarieta Lucas. PCHC Jaca (Jaca): Mª del Pilar Mínguez Sorio. Virginia López Cortés.PCHC Santo Grial (Huesca): Adolfo Cajal Marzal. Madrid. PCHC Mendiguchía Carriche (Leganés): Eduardo Díaz García, Juan Carlos García Álvarez, Francisca García De Blas González, Cristina Guisado Pérez, Alberto López García Franco, Mª Elisa Viñuela Benitez. PCHC El Greco (Getafe): Ana Ballarín González, Mª Isabel Ferrer Zapata, Esther Gómez Suarez, Fernanda Morales Ortiz, Lourdes Carolina Peláez Laguno, José Luis Quintana Gómez, Enrique Revilla Pascual. PCHC Cuzco (Fuenlabrada): M Ángeles Miguel Abanto.PCHC El Soto (Móstoles): Blanca Gutiérrez Teira. PCHC General Ricardos (Madrid): Francisco Ramón Abellán López, Carlos Casado Álvaro, Paulino Cubero González, Santiago Manuel Machín Hamalainen, Raquel Mateo Fernández, Mª Eloisa Rogero Blanco, Cesar Sánchez Arce.PCHC Ibiza (Madrid): Jorge Olmedo Galindo. PCHC Las Américas (Parla): Claudia López Marcos, Soledad Lorenzo Borda, Juan Carlos Moreno Fernández, Belén Muñoz Gómez, Enrique Rodríguez De Mingo. PCHC Mª Ángeles López (Leganés): Juan Pedro Calvo Pascual, Margarita Gómez Barroso, Beatriz López Serrano, Mª Paloma Morso Peláez, Julio Sánchez Salvador, Jeannet Dolores Sánchez Yépez, Ana Sosa Alonso. PCHC Mª Jesús Hereza (Leganés): Mª del Mar Álvarez Villalba. PCHC Pavones (Madrid): Purificación Magán Tapia. PCHC Pedro Laín Entralgo (Alcorcón): Mª Angelica Fajardo Alcántara, Mª Canto De Hoyos Alonso, Mª Aránzazu Murciano Antón. PCHC Pintores (Parla): Manuel Antonio Alonso Pérez, Ricardo De Felipe Medina, Amaya Nuria López Laguna, Eva Martínez Cid De Rivera, Iliana Serrano Flores, Mª Jesús Sousa Rodríguez. PCHC Ramón y Cajal (Alcorcón): Mª Soledad Núñez Isabel, Jesús Mª Redondo Sánchez, Pedro Sánchez Llanos, Lourdes Visedo Campillo.

Data Availability

Regards data sharing, the Aragon Ethics Committee (CEICA, ceica@aragon.es), approved this research without considering the option of data sharing. The data contain sensitive clinical information about the patient, so there are ethical and legal restrictions to sharing the data set. The data are part of the MULTIPAP study and can be requested from the Principal Investigators of the project (Alexandra Prados-Torres at sprados.iacs@aragon.es; Daniel Prados-Torres at uand.prados.sspa@juntadeandalucia.es; and Isabel del Cura at isabel.cura@salud.madrid.org). The MULTIPAP Group may establish future collaborations with other groups based on the same data. However, each new project based on these data must be previously submitted to CEICA for approval.

Funding Statement

This study was funded by Instituto de Salud Carlos III (ISCIII) [grant references PI15/00276, PI15/00572, PI15/00996, PI18/01812, PI18/01303, PI18/01515, RD16/0001/0004, RD16/0001/0005, RD16/0001/0006] and co-funded by the European Regional Development Fund “A way to shape Europe; Research, Development and Innovation National Plan 2013-2016”. CMLH has received a grant from the Fundación para la Investigación e Innovación Biosanitaria de Atención Primaria (FIIBAP) for translation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Research Reviews. 2011;10: 430–439. doi: 10.1016/j.arr.2011.03.003 [DOI] [PubMed] [Google Scholar]
  • 2.Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Review. Perspectives on Psychological Science. 2015;10: 227–237. doi: 10.1177/1745691614568352 [DOI] [PubMed] [Google Scholar]
  • 3.Gallant MP. The influence of social support on chronic illness self-management: A review and directions for research. Health Education and Behavior. 2003;30: 170–195. doi: 10.1177/1090198102251030 [DOI] [PubMed] [Google Scholar]
  • 4.Cohen S. Psychosocial models of the role of social support in the etiology of physical disease. Health Psychol. 1988;7: 269–97. Available: http://www.ncbi.nlm.nih.gov/pubmed/3289916 doi: 10.1037//0278-6133.7.3.269 [DOI] [PubMed] [Google Scholar]
  • 5.Instituto Nacional de Estadistica. Nota Técnica Encuesta Nacional de Salud. España 2017 Principales resultados. 2017. Available: https://www.mscbs.gob.es/estadEstudios/estadisticas/encuestaNacional/encuestaNac2017/ENSE2017_notatecnica.pdf
  • 6.Ahn S, Kim S, Zhang H. Changes in Depressive Symptoms among Older Adults with Multiple Chronic Conditions: Role of Positive and Negative Social Support. International Journal of Environmental Research and Public Health. 2016;14: 16. doi: 10.3390/ijerph14010016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.DiMatteo MR. Social Support and Patient Adherence to Medical Treatment: A Meta-Analysis. Health Psychology. 2004;23: 207–218. doi: 10.1037/0278-6133.23.2.207 [DOI] [PubMed] [Google Scholar]
  • 8.Johnson VR, Jacobson KL, Gazmararian JA, Blake SC. Does social support help limited-literacy patients with medication adherence?. A mixed methods study of patients in the Pharmacy Intervention for Limited Literacy (PILL) Study. Patient Education and Counseling. 2010;79: 14–24. doi: 10.1016/j.pec.2009.07.002 [DOI] [PubMed] [Google Scholar]
  • 9.Lozano-Hernández CM, López-Rodríguez JA, Leiva-Fernández F, Calderón-Larrañaga A, Barrio-Cortes J, Gimeno-Feliu LA, et al. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP study. PLoS ONE. 2020;15: 1–15. doi: 10.1371/journal.pone.0235148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Norbeck J S, A M Lindsey VLC. The development of an instrument to measure social support—PubMed. Nurs Res. 1981;Sep-Oct: 264–9. [PubMed] [Google Scholar]
  • 11.de la Revilla Ahumada L, Bailón E, de Dios Luna J, Delgado A, Prados MA, Fleitas L. [Validation of a functional social support scale for use in the family doctor’s office]. Aten Primaria. 1991;8: 688–92. [PubMed] [Google Scholar]
  • 12.Hughes ME, Waite LJ. Marital biography and health at mid-life. Journal of Health and Social Behavior. 2009;50: 344–358. doi: 10.1177/002214650905000307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Umberson D, Karas Montez J. Social Relationships and Health: A Flashpoint for Health Policy. Journal of Health and Social Behavior. 2010;51: S54–S66. doi: 10.1177/0022146510383501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Li H, Ji Y, Chen T. The roles of different sources of social support on emotional well-being among Chinese elderly. PLoS ONE. 2014;9: 1–8. doi: 10.1371/journal.pone.0090051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Broadhead WE, Gehlbach SH, de Gruy F v, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26: 709–23. Available: http://www.ncbi.nlm.nih.gov/pubmed/3393031 doi: 10.1097/00005650-198807000-00006 [DOI] [PubMed] [Google Scholar]
  • 16.Vaux A. Variations in Social Support Associated with Gender, Ethnicity, and Age. Journal of Social Issues. 1985;41: 89–110. doi: 10.1111/j.1540-4560.1985.tb01118.x [DOI] [Google Scholar]
  • 17.Christov-Moore L, Simpson EA, Coudé G, Grigaityte K, Iacoboni M, Ferrari PF. Empathy: Gender effects in brain and behavior. Neuroscience & Biobehavioral Reviews. 2014;46: 604–627. doi: 10.1016/j.neubiorev.2014.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cable N, Bartley M, Chandola T, Sacker A. Friends are equally important to men and women, but family matters more for men’s well-being. Journal of Epidemiology and Community Health. 2013;67: 166–171. doi: 10.1136/jech-2012-201113 [DOI] [PubMed] [Google Scholar]
  • 19.Kaplan RM, Hartwell SL. Differential effects of social support and social network on physiological and social outcomes in men and women with type II diabetes mellitus. Health Psychol. 1987;6: 387–98. Available: http://www.ncbi.nlm.nih.gov/pubmed/3678167 doi: 10.1037//0278-6133.6.5.387 [DOI] [PubMed] [Google Scholar]
  • 20.Walen HR, Lachman ME. Social Support and Strain from Partner, Family, and Friends: Costs and Benefits for Men and Women in Adulthood. Journal of Social and Personal Relationships. 2000;17: 5–30. doi: 10.1177/0265407500171001 [DOI] [Google Scholar]
  • 21.Fuhrer R, Stansfeld SA. How gender affects patterns of social relations and their impact on health: a comparison of one or multiple sources of support from “close persons”. Soc Sci Med. 2002;54: 811–25. Available: http://www.ncbi.nlm.nih.gov/pubmed/11999495 doi: 10.1016/s0277-9536(01)00111-3 [DOI] [PubMed] [Google Scholar]
  • 22.Caetano S, Silva C, Vettore M. Gender differences in the association of perceived social support and social network with self-rated health status among older adults: a population-based study in Brazil. BMC Geriatrics. 2013;13: 122. doi: 10.1186/1471-2318-13-122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Berkman LF, Soh Y. Social Determinants of Health at Older Ages: The Long Arm of Early and Middle Adulthood. Perspectives in Biology and Medicine. 2017;60: 595–606. doi: 10.1353/pbm.2017.0045 [DOI] [PubMed] [Google Scholar]
  • 24.Chen WCW, Baily JE, Corselli M, Diaz M, Sun B, Xiang G, et al. HHS Public Access. 2016;33: 557–573. doi: 10.1002/stem.1868.Human [DOI] [Google Scholar]
  • 25.Abad-Díez JM, Calderón-Larrañaga A, Poncel-Falcó A, Poblador-Plou B, Calderón-Meza JM, Sicras-Mainar A, et al. Age and gender differences in the prevalence and patterns of multimorbidity in the older population. BMC Geriatrics. 2014;14. doi: 10.1186/1471-2318-14-75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Guallar-Castillón P, Redondo Sendino Á, Banegas JR, López-García E, Rodríguez-Artalejo F. Differences in quality of life between women and men in the older population of Spain. Social Science & Medicine. 2005;60: 1229–1240. doi: 10.1016/j.socscimed.2004.07.003 [DOI] [PubMed] [Google Scholar]
  • 27.Benyamini Y, Blumstein T, Lusky A, Modan B. Gender differences in the self-rated health-mortality association: Is it poor self-rated health that predicts mortality or excellent self-rated health that predicts survival? Gerontologist. 2003;43: 396–405. doi: 10.1093/geront/43.3.396 [DOI] [PubMed] [Google Scholar]
  • 28.Kobayasi R, Tempski PZ, Arantes-Costa FM, Martins MA. Gender differences in the perception of quality of life during internal medicine training: A qualitative and quantitative analysis. BMC Medical Education. 2018;18: 1–14. doi: 10.1186/s12909-018-1378-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mondesir FL, Carson AP, Durant RW, Lewis MW, Safford MM, Levitan EB. Association of functional and structural social support with medication adherence among individuals treated for coronary heart disease risk factors: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Plos One. 2018;13: e0198578. doi: 10.1371/journal.pone.0198578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rueda S. Health Inequalities among Older Adults in Spain: The Importance of Gender, the Socioeconomic Development of the Region of Residence, and Social Support. Women’s Health Issues. 2012;22: e483–e490. doi: 10.1016/j.whi.2012.07.001 [DOI] [PubMed] [Google Scholar]
  • 31.Fernández Vargas AM BZMLFMF. Salud autopercibida, apoyo social y familiar de los pacientes con enfermedad pulmonar obstructiva crónica. Medifarm. 2001;11: 530–539. [Google Scholar]
  • 32.Bird C., & Rieker P. Gender and Health: The Effects of Constrained Choices and Social Policies. Cambridge: Cambridge University Press; 2012. doi: 10.1017/CBO9780511807305 [DOI] [Google Scholar]
  • 33.Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, Poncel-Falcó A, et al. Multimorbidity patterns in primary care: Interactions among chronic diseases using factor analysis. PLoS ONE. 2012;7. doi: 10.1371/journal.pone.0032190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Blasco Patiño F, Martinez López de Letona J, Villares P, Jiménez A, Blasco-Patiño F, Martínez-López de Letona J, et al. El paciente anciano polimedicado: efectos sobre su salud y sobre el sistema sanitario. Información Terapéutica del Sistema Nacional de Salud. 2005;29: 152–162. [Google Scholar]
  • 35.Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ (Online). BMJ Publishing Group; 2015. doi: 10.1136/bmj.h176 [DOI] [PubMed] [Google Scholar]
  • 36.Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9: e102149. doi: 10.1371/journal.pone.0102149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.The Academy of Medical Sciences. Multimorbidity: a priority for global health research. 2018; 1–127. doi: 10.1002/14651858.CD008165.pub4 [DOI] [Google Scholar]
  • 38.Prados-Torres A, del Cura-González I, Prados-Torres D, López-Rodríguez JA, Leiva-Fernández F, Calderón-Larrañaga A, et al. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). Implementation Science. 2017;12: 54. doi: 10.1186/s13012-017-0584-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Govering Body of International Labour (ILO). International Standard Classification of Occupations (ISCO-08). International Labour Office. 2012;1: 615. [Google Scholar]
  • 40.Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C. Propuestas de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011. Gaceta Sanitaria. 2013;27: 263–272. doi: 10.1016/j.gaceta.2012.12.009 [DOI] [PubMed] [Google Scholar]
  • 41.Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24: 67–74. doi: 10.1097/00005650-198601000-00007 [DOI] [PubMed] [Google Scholar]
  • 42.Oppe M, Devlin NJ, van Hout B, Krabbe PFM, de Charro F. A program of methodological research to arrive at the new international eq-5d-5l valuation protocol. Value in Health. 2014;17: 445–453. doi: 10.1016/j.jval.2014.04.002 [DOI] [PubMed] [Google Scholar]
  • 43.Herdman M, Gudex C, Lloyd a., Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research. 2011;20: 1727–1736. doi: 10.1007/s11136-011-9903-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value in Health. 2012;15: 708–715. doi: 10.1016/j.jval.2012.02.008 [DOI] [PubMed] [Google Scholar]
  • 45.Bellón JA, Delgado A, Luna J LP. Validez y fiabilidad del cuestionario de apoyo social funcional Duke-UNC-11. Atención Primaria. 1996;18: 153–63. [PubMed] [Google Scholar]
  • 46.Broadhead WE, Gehlbach SH, de Gruy F V, Kaplan BH, B W.E., G S.H., et al. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26: 709–723. doi: 10.1097/00005650-198807000-00006 [DOI] [PubMed] [Google Scholar]
  • 47.Ayala A, Rodríguez-Blázquez C, Frades-Payo B, Forjaz MJ, Martínez-Martín P, Fernández-Mayoralas G, et al. Propiedades psicométricas del Cuestionario de Apoyo Social Funcional y de la Escala de Soledad en adultos mayores no institucionalizados en España. Gaceta Sanitaria. 2012;26: 317–324. doi: 10.1016/j.gaceta.2011.08.009 [DOI] [PubMed] [Google Scholar]
  • 48.Pinilla García A. La mujer en la posguerra franquista a través de la Revista Medina (1940–1945). Arenal—Revista de Historia de las Mujeres. 2006;13: 153–179. doi: 10.30827/arenal.vol13.num1.153–179 [DOI] [Google Scholar]
  • 49.Mena E, Kroll LE, Maier W, Bolte G. Gender inequalities in the association between area deprivation and perceived social support: a cross-sectional multilevel analysis at the municipality level in Germany. BMJ Open. 2018;8: e019973. doi: 10.1136/bmjopen-2017-019973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Matud P, Carballeira M, López M, Marrero R, Ibáñez I. Apoyo Social Y Salud: Un Analisis De Genero. Salud Mental. 2002;25: 32–37. [Google Scholar]
  • 51.Spijker J. Diez años de mejoras en la salud y los hábitos de las generaciones nacidas entre 1945 y 1969 en España. Perspectives Demogràfiques. 2019; 1–4. doi: 10.46710/ced.pd.esp.17 [DOI] [Google Scholar]
  • 52.López Doblas J. Las Mujeres Viudas en España. Research on Ageing and Social Policy. 2016;4: 22. doi: 10.17583/rasp.2016.1731 [DOI] [Google Scholar]
  • 53.Martín-Fernández J, Ariza-Cardiel G, Polentinos-Castro E, Sanz-Cuesta T, Sarria-Santamera A, del Cura-González I. Explaining differences in perceived health-related quality of life: a study within the Spanish population. Gaceta Sanitaria. 2018;32: 447–453. doi: 10.1016/j.gaceta.2017.05.016 [DOI] [PubMed] [Google Scholar]
  • 54.Borrell C, Rohlfs I, Artazcoz L, Muntaner C. Desigualdades en salud según la clase social en las mujeres. ¿Cómo influye el tipo de medida de la clase social? Gaceta Sanitaria. 2004;18: 75–82. doi: 10.1157/13061997 [DOI] [PubMed] [Google Scholar]
  • 55.Cuéllar-Flores I, Dresch V. Validación del cuestionario de Apoyo Social Funcional Duke-UNK-11 en personas cuidadoras. Ridep · No. 2012;34: 89–101. [Google Scholar]
  • 56.Mas-Expósito L, Amador-Campos JA, Gómez-Benito J, Lalucat-Jo L. Validation of the modified DUKE-UNC Functional Social Support Questionnaire in patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology. 2012;48: 1675–1685. doi: 10.1007/s00127-012-0633-3 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Andrea Gruneir

16 Feb 2022

PONE-D-21-30179

Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP Project.

PLOS ONE

Dear Dr. Lozano Hernández,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

Thank you for submitting your work to PLOS ONE and for your patience while it was under review. As you can see, we now have 2 reviews on your submission. Both reviewers were quite positive about this work and highlight their interests in it and strengths of the manuscript. At the same time, though, they both pointed out some important considerations that you should consider addressing. In particular, Reviewer 1, makes some very clear suggestions on improving the link between the conceptual undermining of your approach and the actual data analysis and explanation. 

==============================

Please submit your revised manuscript by Apr 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Andrea Gruneir

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/fileid=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf".

2. Thank you for stating the following financial disclosure:

“This study was funded by Instituto de Salud Carlos III (ISCIII) [grant references PI15/00276, PI15/00572, PI15/00996, PI18/01812, PI18/01303, PI18/01515, RD16/0001/0004, RD16/0001/0005, RD16/0001/0006] and co-funded by the European Regional Development Fund “A way to shape Europe; Research, Development and Innovation National Plan 2013-2016”. CMLH has received a grant from the Fundación para la Investigación e Innovación Biosanitaria de Atención Primaria (FIIBAP) for translation.”

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“This study was funded by Instituto de Salud Carlos III (ISCIII) [grant references PI15/00276,

PI15/00572, PI15/00996, PI18/01812, PI18/01303, PI18/01515, RD16/0001/0004,

RD16/0001/0005, RD16/0001/0006] and co-funded by the European Regional Development

Fund “A way to shape Europe; Research, Development and Innovation National Plan 2013-

2016”. CMLH has received a grant from the Fundación para la Investigación e Innovación

Biosanitaria de Atención Primaria (FIIBAP) for translation.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This study was funded by Instituto de Salud Carlos III (ISCIII) [grant references PI15/00276, PI15/00572, PI15/00996, PI18/01812, PI18/01303, PI18/01515, RD16/0001/0004, RD16/0001/0005, RD16/0001/0006] and co-funded by the European Regional Development Fund “A way to shape Europe; Research, Development and Innovation National Plan 2013-2016”. CMLH has received a grant from the Fundación para la Investigación e Innovación Biosanitaria de Atención Primaria (FIIBAP) for translation.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

6. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

7. One of the noted authors is a group or consortium [MULTIPAP group]. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

8. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate ""supporting information"".

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript uses survey data from Spanish health centers to assess the sex differences in social support among older polymedicated adults. Overall, it is fairly well written and easy to follow. Please see below for my comments.

1. For the most part, the authors do well to use politically correct language when referring to older adults. However, on line 45, per the Gerontological Society of America’s policy on language regarding the older population, I suggest replacing the term ‘eldery people’ with a more neutral term (e.g., older adults, older people). See for (Lundebjerg et al., 2017) for details on this policy.

CITED SOURCE: Lundebjerg, Nancy E., Daniel E. Trucil, Emily C. Hammond, and William B. Applegate. 2017. “When It Comes to Older Adults, Language Matters: Journal of the American Geriatrics Society Adopts Modified American Medical Association Style.” Journal of the American Geriatrics Society 65(7):1386–88. doi: 10.1111/jgs.14941.

2. The authors do well to distinguish between social networks and social support (lines 56-65). However, after introducing the concept of networks (including size, density, homogeneity, etc) in the Introduction, it was a little disappointing to see structural social support later operationalized simply as marital status and number of cohabitants in the home (lines 122-123). While these measures are often indicative of social support, their mere presence does not automatically guarantee social support. For instance, poor marriages might actually cause more strain than support (de Jong Gierveld et al. 2009). I realize that data limitations are always going to be an issue, but it seems that it is at least acknowledging the lack of social network data and marital quality as limitations in this study.

CITED SOURCE: Jenny de Jong Gierveld, Marjolein Broese van Groenou, Adriaan W. Hoogendoorn, Johannes H. Smit, Quality of Marriages in Later Life and Emotional and Social Loneliness, The Journals of Gerontology: Series B, Volume 64B, Issue 4, July 2009, Pages 497–506, https://doi.org/10.1093/geronb/gbn043

3. In the Materials and Methods section, the authors choose to separate functional support into ‘confident support” and “affective support” (lines 131-133). If they are going to make this distinction methodologically, it should be preceded with conceptual justification in the Introduction section.

4. I don’t understand the values given in lines 175-178). They do not seem to match those in Table 3. The bivariate comparisons given in the text do not make sense to me because they are not dichotomous outcomes. Rather there appears to be three response categories to each outcome.

5. I am confused by the sentence on line 215 that reads “The increasing feminization of old age has meant that widowhood is a mostly female experience.” What does this mean? Are the authors trying to say that women are more likely to experience widowhood because they tend to live longer than men?

6. The sentence on lines 241-243 the authors say that their heterogeneous sample “is representative of the general multimorbid and polymedicated population, increasing its external validity.” But it seems to me that the external validity depends more on the sampling methodology (i.e., random sampling drawn from a representative sampling frame) rather than the sample demographics. It is difficult to tell if participants were randomly selected or if a convenience sampling method was used instead. Perhaps more importantly, however, the participants appear to have first been contacted in health centers, which—if true—would not make it a representative sample of the general population since only those who went to the health centers were eligible for being selected into the study. These distinctions should be noted in the manuscript.

Reviewer #2: I have just read the manuscript entitled "Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP Project", an interesting work exploring determinants of social support perceived by sex. The study is focused on polymedicated older adults with multimorbidity. After reading the manuscript, I have the following comments:

- The article is focused in older adults, although only in those aged 65-74 years. Why people older than 75 were not considered in the sample?

- All the instruments used in this study have been previously validated in other samples. I wonder whether the authors could provide data on internal consistency (e.g., Cronbach’s alpha for unidimensional scales) according to the sample considered in this study.

- In Table 4, the 95% CI associated to “Number of drugs” in men cannot provide a significant p-value. This would be checked and also revised in the Results section in the main text.

- The authors have found an association between lower perception of social support and multimorbidity in men. This result is not observed in women and should be discussed.

- Potential limitations of this study should be highlighted in the Discussion section.

Minor comments:

- Line 101: "Random sampling". Which type of random sampling was used?

- Lines 141-142: “Explanatory linear regression models”. Why explanatory?

- Lines 190-192: “In contrast, a higher number of diseases was associated with a lower social support score; it fell by 0.4 points (95% CI -0.87–0.30) for each disease”. Please revise the use of hyphen in confidence intervals when negative values are reported. On the other hand, it is not a significant result.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Jul 27;17(7):e0268218. doi: 10.1371/journal.pone.0268218.r002

Author response to Decision Letter 0


31 Mar 2022

We are very grateful for your evaluation of our manuscript entitled "Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP Study"

We appreciate the comments of the reviewers and editors and have made the suggested changes. We have attached the reviewers' response.

We hope that these changes will contribute to improve the quality of the manuscript and the interest of potential readers.

On behalf of the research team,

Best regards,

Cristina María Lozano Hernández

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Thomas Penzel

26 Apr 2022

Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP Study.

PONE-D-21-30179R1

Dear Dr. Lozano Hernández,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Thomas Penzel

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: I have read the last version of the manuscript entitled "Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP Study" and the authors have adequately addressed all my previous comments.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Thomas Penzel

28 Apr 2022

PONE-D-21-30179R1

Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP Study.

Dear Dr. Lozano-Hernández:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Thomas Penzel

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Regards data sharing, the Aragon Ethics Committee (CEICA, ceica@aragon.es), approved this research without considering the option of data sharing. The data contain sensitive clinical information about the patient, so there are ethical and legal restrictions to sharing the data set. The data are part of the MULTIPAP study and can be requested from the Principal Investigators of the project (Alexandra Prados-Torres at sprados.iacs@aragon.es; Daniel Prados-Torres at uand.prados.sspa@juntadeandalucia.es; and Isabel del Cura at isabel.cura@salud.madrid.org). The MULTIPAP Group may establish future collaborations with other groups based on the same data. However, each new project based on these data must be previously submitted to CEICA for approval.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES